SS
LABU icon

SBI Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SBI Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675K Buy
2,311
+1,100
+91% +$210K 0.02% 350
2026
Q1 		$201K Sell
1,211
-454
-27% -$74.5K 0.01% 622
2025
Q4 		$265K Sell
1,665
-1,398
-46% -$192K 0.01% 546
2025
Q3 		$287K Sell
3,063
-325
-10% -$23K 0.01% 529
2025
Q2 		$193K Buy
3,388
+385
+13% +$20.4K 0.01% 602
2025
Q1 		$183K Buy
3,003
+295
+11% +$25.1K 0.01% 555
2024
Q4 		$244K Buy
+2,708
New +$319K 0.01% 490

Other funds holding LABU

HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
PS
PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

SBI Securities's LABU Position: Q2 2026 in Review

SBI Securities increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 91% in Q2 2026, buying an estimated $210K and bringing the position to 2,311 shares worth $675K. The position accounts for 0.02% of the portfolio, ranked #350.

SBI Securities first reported a position in LABU in Q4 2024 and has held it in 7 quarters since. 6 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • SBI Securities held 2,311 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $675K as of Q2 2026.
  • SBI Securities bought 1,100 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $210K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.02% of SBI Securities's portfolio in Q2 2026, its #350 holding.
  • SBI Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2024 and has held it in 7 quarters since.
  • 6 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.